ESR1 and breast adenocarcinoma: The study comprehensively investigated the anticancer properties of SP extracts utilizing a network pharmacology approach, DMBA-induced mammary gland carcinogenesis, and the MCF-7 cell line, representing human breast adenocarcinoma expressing the estrogen receptor.